Veracyte, Inc. (VCYT)Artemis Investment Management LLP opened a new position $37.5M

639K

Shares reported

0.33%

Disclosed portfolio weight

$37.5M

Reported value

Holdings as of

Jun 30, 2026

Filed

Jul 23, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 23, 2025Federal contract · $130K obligatedDepartment of Veterans Affairs awarded VERACYTE, INC.: $130K obligated to date
2. Dec 31, 2025Federal contract · $716K obligatedDepartment of Veterans Affairs awarded VERACYTE, INC.: $716K obligated to date
3. Jan 8, 2026Federal contract · $345K obligatedDepartment of Veterans Affairs awarded VERACYTE, INC.: $345K obligated to date
4. May 29, 2026Federal contract · $97K obligatedDepartment of Veterans Affairs awarded VERACYTE, INC.: $97K obligated to date
5. Jun 10, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“As further described in Item 5.07 to this Current Report on Form 8-K (this “Report”), on June 10, 2026, at the 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Veracyte, Inc. (the “Company”), the Company’s stockholders approved an amendment to the Company’s 2023 Equity Incentive Plan (the “2023 Plan”) to increase the number of shares of the Company’s Common Stock, $0.001 par value, reserved for issuance…”

What came next

1. Jul 30, 2026Company filing · Form 8-K · ResultsReported its results
2. Sep 10, 2026Company filing · Form 8-K · Material agreement, Acquisition or saleCompleted buying or selling a business or assets, and signed an important agreement (and 1 more item)“On September 14, 2026, Veracyte completed its acquisition of Convergent pursuant to the terms of the Merger Agreement. To the extent required by this Item 2.01, the information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this”

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Veracyte, Inc.

For Veracyte, Inc., OQRO holds 9 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VCYT page.

How this filing works

• SEC Form 13F

Other disclosures at Veracyte, Inc.

• USAspending.gov award recordOct 1, 2026
• USAspending.gov award recordSep 29, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its VCYT page.